SI2318042T1 - Cepivo proti HPV - Google Patents

Cepivo proti HPV

Info

Publication number
SI2318042T1
SI2318042T1 SI200931047T SI200931047T SI2318042T1 SI 2318042 T1 SI2318042 T1 SI 2318042T1 SI 200931047 T SI200931047 T SI 200931047T SI 200931047 T SI200931047 T SI 200931047T SI 2318042 T1 SI2318042 T1 SI 2318042T1
Authority
SI
Slovenia
Prior art keywords
vaccine against
against hpv
hpv
vaccine
Prior art date
Application number
SI200931047T
Other languages
English (en)
Inventor
Dominique Descamps
Sandra Giannini
Nicolas Lecrenier
Jean Stephenne
Martine Anne Cecile Wettendorff
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of SI2318042T1 publication Critical patent/SI2318042T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
SI200931047T 2008-07-31 2009-07-29 Cepivo proti HPV SI2318042T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8510108P 2008-07-31 2008-07-31
US17656109P 2009-05-08 2009-05-08
PCT/EP2009/059820 WO2010012780A1 (en) 2008-07-31 2009-07-29 Vaccine against hpv
EP09781248.1A EP2318042B1 (en) 2008-07-31 2009-07-29 Vaccine against hpv

Publications (1)

Publication Number Publication Date
SI2318042T1 true SI2318042T1 (sl) 2014-12-31

Family

ID=41139260

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200931047T SI2318042T1 (sl) 2008-07-31 2009-07-29 Cepivo proti HPV

Country Status (26)

Country Link
US (1) US20110189229A1 (sl)
EP (1) EP2318042B1 (sl)
JP (1) JP6022159B2 (sl)
KR (1) KR20110053340A (sl)
CN (1) CN102159239A (sl)
AU (1) AU2009275909A1 (sl)
BR (1) BRPI0916732B1 (sl)
CA (1) CA2732436C (sl)
CO (1) CO6341567A2 (sl)
DK (1) DK2318042T3 (sl)
DO (1) DOP2011000031A (sl)
EA (1) EA201170264A1 (sl)
ES (1) ES2519490T3 (sl)
HR (1) HRP20141063T1 (sl)
IL (1) IL210977A0 (sl)
MA (1) MA32554B1 (sl)
MX (1) MX2011001218A (sl)
NZ (1) NZ590919A (sl)
PE (1) PE20110327A1 (sl)
PL (1) PL2318042T3 (sl)
PT (1) PT2318042E (sl)
RS (1) RS53607B1 (sl)
SI (1) SI2318042T1 (sl)
SM (1) SMT201400170B (sl)
WO (1) WO2010012780A1 (sl)
ZA (1) ZA201100889B (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG177269A1 (en) 2009-06-25 2012-02-28 Glaxosmithkline Biolog Sa Novel human papillomavirus (hpv) protein constructs and their use in the prevention of hpv disease
CN102178944A (zh) * 2010-09-17 2011-09-14 大连雅立峰生物制药有限公司 人乳头瘤病毒16和18型l1蛋白在昆虫细胞中的表达及应用
CN102229660B (zh) * 2011-05-25 2015-04-22 厦门大学 截短的人乳头瘤病毒33型l1蛋白
KR101559622B1 (ko) * 2012-07-30 2015-10-13 중앙대학교 산학협력단 인유두종바이러스 바이러스 유사입자의 고효율 정제방법
EA201790365A1 (ru) * 2014-09-11 2017-07-31 Кадила Хелзкэр Лимитед Антигены вируса папилломы человека с хорошими иммунологическими свойствами и содержащая их вакцина
RU2628693C1 (ru) * 2016-11-10 2017-08-21 федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "ФНИЦЭМ им. Н.Ф. Гамалеи" Минздрава России) РЕКОМБИНАНТНЫЙ ГЕН L1HPV16, РЕКОМБИНАНТНАЯ ПЛАЗМИДА pQE-L1/16, БЕЛОК L1HPV16 И ИХ ПРИМЕНЕНИЕ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
US20070014810A1 (en) * 2003-12-31 2007-01-18 Denise Baker Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
CA2566620C (en) * 2004-06-16 2014-03-11 Glaxosmithkline Biologicals S.A. Vaccine against hpv16 and hpv18 and at least another hpv type slected from hpv 31, 45 or 52
US7758866B2 (en) * 2004-06-16 2010-07-20 Glaxosmithkline Biologicals, S.A. Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
MX2007013472A (es) * 2005-04-26 2008-04-02 Glaxosmithkline Biolog Sa Vacuna.

Also Published As

Publication number Publication date
PL2318042T3 (pl) 2015-02-27
JP6022159B2 (ja) 2016-11-09
SMT201400170B (it) 2015-01-15
EP2318042B1 (en) 2014-08-20
CA2732436C (en) 2018-01-16
CN102159239A (zh) 2011-08-17
CA2732436A1 (en) 2010-02-04
MA32554B1 (fr) 2011-08-01
PT2318042E (pt) 2014-11-05
EA201170264A1 (ru) 2011-08-30
IL210977A0 (en) 2011-04-28
CO6341567A2 (es) 2011-11-21
DK2318042T3 (da) 2014-11-10
MX2011001218A (es) 2011-03-15
NZ590919A (en) 2012-10-26
WO2010012780A1 (en) 2010-02-04
RS53607B1 (en) 2015-04-30
KR20110053340A (ko) 2011-05-20
EP2318042A1 (en) 2011-05-11
BRPI0916732A2 (pt) 2017-01-31
PE20110327A1 (es) 2011-06-29
AU2009275909A1 (en) 2010-02-04
JP2011529475A (ja) 2011-12-08
ZA201100889B (en) 2012-04-25
BRPI0916732B1 (pt) 2021-06-29
ES2519490T3 (es) 2014-11-07
HRP20141063T1 (hr) 2015-01-02
DOP2011000031A (es) 2011-02-28
US20110189229A1 (en) 2011-08-04

Similar Documents

Publication Publication Date Title
ZA201101481B (en) Vaccine
IL217008A0 (en) Vaccine
HK1130807A1 (en) Improved hpv vaccines
HK1143085A1 (en) Low-additive influenza vaccines
HRP20151124T1 (en) Vaccine
GB0810305D0 (en) Influenza vaccination
IL208660A0 (en) Coccididosis vaccines
GB0822001D0 (en) Vaccine
PL2358386T3 (pl) Zoptymalizowane szczepionki na grypę
GB201006165D0 (en) Vaccine
GB0810710D0 (en) Vaccine
ZA201007402B (en) Vaccine
ZA201100962B (en) Influenza vaccines
ZA201100889B (en) Vaccine against hpv
GB0816284D0 (en) Vaccine
GB0816447D0 (en) Vaccine
GB201000522D0 (en) Vaccine
GB0801326D0 (en) Vaccines
IL217194A0 (en) Vaccine
EP2240199A4 (en) INFLUENZA VACCINES
GB0920319D0 (en) HPV vaccine
GB0810215D0 (en) Vaccine
AP2010005295A0 (en) Vaccine
AU2008267307A1 (en) Vaccine
GB0802108D0 (en) Vaccine